Hyesoon Choi
Psychiatric/Mental Health · Everett, WANPI 1851699573
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 396 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 396 payments — averaging $20.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$771
- Axsome Therapeutics, Inc.$753
- Alkermes, Inc.$445
- Corium, LLC$407
- plus $3K from 20 others
What the payments were for
- Food & beverage$7,92399%
- Education$741%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 78 | $1,512 |
| AbbVie(2 entities) | 81 | $1,446 |
| Otsuka America Pharmaceutical, Inc. | 33 | $771 |
| Axsome Therapeutics, Inc. | 31 | $753 |
| Alkermes, Inc. | 20 | $445 |
| Corium, LLC | 18 | $407 |
| Supernus Pharmaceuticals, Inc. | 26 | $398 |
| Tris Pharma Inc | 21 | $322 |
| Lundbeck LLC | 11 | $288 |
| Neurocrine Biosciences, Inc. | 4 | $223 |
| Idorsia Pharmaceuticals US Inc | 10 | $188 |
| Teva Pharmaceuticals USA, Inc. | 8 | $182 |
| Collegium Pharmaceutical, Inc. | 11 | $169 |
| E.r. Squibb & Sons, L.L.C. | 8 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $165 |
| Johnson & Johnson | 7 | $128 |
| Biogen | 1 | $80 |
| Vanda Pharmaceuticals Inc. | 4 | $79 |
| Sunovion Pharmaceuticals Inc. | 5 | $71 |
| Noven Therapeutics, LLC | 2 | $47 |
| Jazz Pharmaceuticals Inc. | 2 | $46 |
| Bausch Health US, LLC | 2 | $42 |
| Alfasigma USA, Inc. | 2 | $27 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
| Merck | 1 | $15 |
| Neuronetics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,997 in reported general payments places this provider in the 95th percentile of 931 psychiatric/mental health providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 13 | $24,631 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 29 | $2,551 |
| Desvenlafaxine ErDesvenlafaxine | 12 | $1,751 |
| Zolpidem Tartrate ErZolpidem Tartrate | 24 | $1,657 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 45 | $1,579 |
| Alprazolam | 38 | $567 |
| Methylphenidate Hcl | 23 | $511 |
| Olanzapine | 12 | $497 |
| Bupropion Hcl SrBupropion Hcl | 20 | $486 |
| Guanfacine Hcl | 19 | $445 |
| Quetiapine Fumarate | 34 | $407 |
| Clonazepam | 45 | $317 |
| Lamotrigine | 39 | $263 |
| Divalproex Sodium | 12 | $201 |
| Bupropion XlBupropion Hcl | 24 | $181 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,512 | $24,63113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 931 psychiatric/mental health providers in Washington.
Other psychiatric/mental health in Everett
- Angela KokinakosEverett$9K
- Sandra CarrierEverett$7K
- Jana RobisonEverett$5K
- Laura PerezEverett$5K
- Isabel Zaragoza-SanchezEverett$4K
- Angela CombsRichland$121K
- Ashley McGinnisAuburn$26K
- Courtney YantPuyallup$26K
- Dawn MasonSpokane$25K
- Jennifer WilsonYakima$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.